Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Research and Developments of Therapeutic Biologics	253.00K	10.21M	880.00K	471.00K
Research and Developments of Therapeutic Biologics Growth	-97.52%	1060.68%	86.84%	-
Total	253.00K	10.21M	880.00K	471.00K
Total Growth	-97.52%	1060.68%	86.84%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Source: S&P Global Market Intelligence.